CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 44 enrolled
Drug / intervention
Turbo-Elite Laser Catheterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02307370
NCT02307370N/ACompleted
CompareCT.gov

Atherectomy By Laser Ablation With Turbo-Elite

Spectranetics Corporation·interventional·Posted Dec 4, 2014·Updated Aug 27, 2021

In Brief

A clinical study evaluating Turbo-Elite Laser Catheter for Peripheral Arterial Disease and Peripheral Vascular Disease. Completed, enrolled 44 participants.

Detailed Summary

The primary objective for this study is to prove the safety and effectiveness of the Spectranetics Turbo-Elite catheter in atherectomy treatment for infrainguinal arteries with catheter to vessel sizing of at least 50%.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Arterial Disease, Peripheral Vascular Disease
Countries--
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 4, 2014
Enrollment StartDec 1, 2014
Primary CompletionNov 1, 2015
Study CompletionNov 1, 2016
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 11.6 years ago

Interventions

Turbo-Elite Laser Catheterdevice

Application of laser energy to remove blockage